Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease

Human Brain Mapping

Volumn 36, Issue 7, 2015, Pages 2826-2841

  Soldan, Anja ^a,f   Pettigrew, Corinne ^a   Lu, Yi ^b,j   Wang, Mei Cheng ^b,j   Selnes, Ola ^a,f   Albert, Marilyn ^a,e,f   Brown, Timothy ^c,g   Ratnanather, J Tilak ^c,g   Younes, Laurent ^d,g   Miller, Michael I ^c,g   Rodzon, Barbara ^e   Gottesman, Rebecca ^f   Sacktor, Ned ^f   McKhann, Guy ^f   Turner, Scott ^f   Farrington, Leonie ^f   Grega, Maura ^f   D'Agostino, Daniel ^f   Feagen, Sydney ^f   Dolan, David ^f   Dolan, Hillary ^f   Mori, Susumu ^g   Kolasny, Anthony ^g   Oishi, Kenichi ^g   Schneider, William ^g   O'Brien, Richard ^h   Moghekar, Abhay ^h   Spangler, Abby ^h   Scherer, Roberta ⁱ   Meinert, Curt ⁱ   Shade, David ⁱ   Ervin, Ann ⁱ   Jones, Jennifer ⁱ   Toepfner, Matt ⁱ   Parlett, Lauren ⁱ   Patterson, April ⁱ   Lassiter, Lisa ⁱ   Cai, Qing ^j   Troncoso, Juan ^k   Crain, Barbara ^k   Pletnikova, Olga ^k   Rudow, Gay ^k   Fisher, Karen ^k   Cernansky, John ^l   Holtzman, David ^l   Knopman, David ^l   Kukull, Walter ^l   McArdle, John ^l   Buckholtz, Neil ^l   Hsiao, John ^l   Ryan, Laurie ^l   Evans, Jovier ^l   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Johns Hopkins University   (United States)

^d Johns Hopkins University   (United States)

^e The Administrative Core   (United States)

^f Clinical Core   (United States)

^g The Imaging Core   (United States)

^h The Biospecimen Core   (United States)

ⁱ The Informatics Core   (United States)

^j Biostatistics and Computational Biology Core   (United States)

^k Center for Neuroscience and Regenerative Medicine   (United States)

^l NONE

more..

Author keywords

Amygdala; Apolipoprotein E; Education; Entorhinal cortex; Hippocampus; Mild cognitive impairment; Structural MRI

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; COGNITIVE RESERVE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTORHINAL CORTEX; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIAL TEMPORAL ATROPHY; MEDIAL TEMPORAL LOBE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; AGED; AMYGDALA; ATROPHY; COGNITIVE DEFECT; DISEASE COURSE; GENETICS; HIPPOCAMPUS; LONGITUDINAL STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PRODROMAL SYMPTOM; PROGNOSIS;

AGED; ALZHEIMER DISEASE; AMYGDALA; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; ATROPHY; COGNITIVE DYSFUNCTION; COGNITIVE RESERVE; DISEASE PROGRESSION; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PRODROMAL SYMPTOMS; PROGNOSIS;

EID: 84931956173     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22810     Document Type: Article

References (85)

1. Albert SA, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011): Diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:270-279.
2. Albert M, Soldan A, Gottesman R, McKhann G, Sacktor N, Farrington L, Grega M, Turner R, Lu Y, Li S, Wang MC, Selnes O (2014): Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype. Curr Alzheimer Res 11:773-784.
3. Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, Mistur R, Tsui WH, de Leon MJ (2010): Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging 31:1077-1088.
4. Arenaza-Urquijo EM, Molinuevo JL, Sala-Llonch R, Sole-Padulles C, Balasa M, Bosch B, Olives J, Antonell A, Llado A, Sanchez-Valle R, Rami L, Bartres-Faz D (2013): Cognitive reserve proxies relate to gray matter loss in cognitively healthy elderly with abnormal cerebrospinal fluid amyloid-beta levels. J Alzheimers Dis 35:715-726.
5. Atiya M, Hyman BT, Albert MS, Killiany R (2003): Structural magnetic resonance imaging in established and prodromal Alzheimer disease: A review. Alzheimer Dis Assoc Disord 17:177-195.
6. Barulli D, Stern Y (2013): Efficiency, capacity, compensation, maintenance, plasticity: Emerging concepts in cognitive reserve. Trends Cogn Sci 17:502-509.
7. Barulli DJ, Rakitin BC, Lemaire P, Stern Y (2013): The influence of cognitive reserve on strategy selection in normal aging. J Int Neuropsychol Soc 19:841-844.
8. Beg MF, Miller MI, Trouve A, Younes L (2005): Computing metrics via geodesics on flows of diffeomorphisms. Int J Comput Vis 61:139-157.
9. Benzinger TL, Blazey T, Jack CR Jr, Koeppe RA, Su Y, Xiong C, Raichle ME, et al. (2014): Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A 110:E4502-E4509.
10. Blasko I, Jellinger K, Kemmler G, Krampla W, Jungwirth S, Wichart I, Tragl KH, Fischer P (2008): Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Neurobiol Aging 29:1-11.
11. Bobinski M, de Leon MJ, Wegiel J, Desanti S, Convit A, Saint Louis LA, Rusinek H, Wisniewski HM (2000): The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 95:721-725.
12. Braak H, Braak E (1991): Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
13. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006): Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404.
14. Burggren AC, Zeineh MM, Ekstrom AD, Braskie MN, Thompson PM, Small GW, Bookheimer SY (2008): Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 41:1177-1183.
15. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Thompson PM, Reiman EM, Jack CR Jr, Fox NC, Jagust WJ, Harvey DJ, Beckett LA, Gamst A, Aisen PS, Petersen RC, Weiner MW (2011): Impact of apolipoprotein E4-cerebrospinal fluid beta-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment. Alzheimers Dement 7:514-520.
16. Cohen RM, Small C, Lalonde F, Friz J, Sunderland T (2001): Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 57:2223-2228.
17. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993): Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
18. Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, Grenander U, Miller MI (1998): Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Natl Acad Sci USA 95:11406-11411.
19. Csernansky JG, Wang L, Swank J, Miller JP, Gado M, McKeel D, Miller MI, Morris JC (2005): Preclinical detection of Alzheimer's disease: Hippocampal shape and volume predict dementia onset in the elderly. Neuroimage 25:783-792.
20. Czernochowski D, Fabiani M, Friedman D (2008): Use it or lose it? SES mitigates age-related decline in a recency/recognition task. Neurobiol Aging 29:945-958.
21. Donix M, Burggren AC, Suthana NA, Siddarth P, Ekstrom AD, Krupa AK, Jones M, Rao A, Martin-Harris L, Ercoli LM, Miller KJ, Small GW, Bookheimer SY (2010): Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism. Neuroimage 53:37-43.
22. Edland SD, Xu Y, Plevak M, O'Brien P, Tangalos EG, Petersen RC, Jack CR Jr (2002): Total intracranial volume: Normative values and lack of association with Alzheimer's disease. Neurology 59:272-274.
23. Farias ST, Mungas D, Reed B, Carmichael O, Beckett L, Harvey D, Olichney J, Simmons A, Decarli C (2012): Maximal brain size remains an important predictor of cognition in old age, independent of current brain pathology. Neurobiol Aging 33:1758-1768.
24. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997): Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349-1356.
25. Habeck C, Rakitin BC, Moeller J, Scarmeas N, Zarahn E, Brown T, Stern Y (2005): An event-related fMRI study of the neural networks underlying the encoding, maintenance, and retrieval phase in a delayed-match-to-sample task. Brain Res Cogn Brain Res 23:207-220.
26. Honea RA, Vidoni E, Harsha A, Burns JM (2009): Impact of APOE on the healthy aging brain: A voxel-based MRI and DTI study. J Alzheimers Dis 18:553-564.
27. Hostage CA, Choudhury KR, Murali Doraiswamy P, Petrella JR (2013): Mapping the effect of the apolipoprotein E genotype on 4-year atrophy rates in an Alzheimer disease-related brain network. Radiology 271:211-219.
28. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982): A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572.
29. Hutchison JL, Shokri-Kojori E, Lu H, Rypma B (2013): A BOLD perspective on age-related neurometabolic-flow coupling and neural efficiency changes in human visual cortex. Front Psychol 4:244.
30. Jack CR Jr, Dickson DW, Parisi JE, Xu YC, Cha RH, O'Brien PC, Edland SD, Smith GE, Boeve BF, Tangalos EG, Kokmen E, Petersen RC (2002): Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 58:750-757.
31. Jack CR Jr, Shiung MM, Gunter JL, O'Brien PC, Weigand SD, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Cha RH, Tangalos EG, Petersen RC (2004): Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 62:591-600.
32. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010): Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9:119-128.
33. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013): Tracking pathophysiological processes in Alzheimer's disease: An updated hypothetical model of dynamic biomarkers. Lancet Neurol 12:207-216.
34. Jagust W, Gitcho A, Sun F, Kuczynski B, Mungas D, Haan M (2006): Brain imaging evidence of preclinical Alzheimer's disease in normal aging. Ann Neurol 59:673-681.
35. Jenkins R, Fox NC, Rossor AM, Harvey RJ, Rossor MN (2000): Intracranial volume and Alzheimer disease: Evidence against the cerebral reserve hypothesis. Arch Neurol 57:220-224.
36. Joshi SC, Miller MI (2000): Landmark matching via large deformation diffeomorphisms. IEEE Trans Image Process 9:1357-1370.
37. Kantarci K, Jack CR Jr (2004): Quantitative magnetic resonance techniques as surrogate markers of Alzheimer's disease. NeuroRx 1:196-205.
38. Kerchner GA, Hess CP, Hammond-Rosenbluth KE, Xu D, Rabinovici GD, Kelley DA, Vigneron DB, Nelson SJ, Miller BL (2010): Hippocampal CA1 apical neuropil atrophy in mild Alzheimer disease visualized with 7-T MRI. Neurology 75:1381-1387.
39. Kerchner GA, Bernstein JD, Fenesy MC, Deutsch GK, Saranathan M, Zeineh MM, Rutt BK (2013): Shared vulnerability of two synaptically-connected medial temporal lobe areas to age and cognitive decline: A seven tesla magnetic resonance imaging study. J Neurosci 33:16666-16672.
40. Kim J, Basak JM, Holtzman DM (2009): The role of apolipoprotein E in Alzheimer's disease. Neuron 63:287-303.
41. Liu Y, Julkunen V, Paajanen T, Westman E, Wahlund LO, Aitken A, Sobow T, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Spenger C, Lovestone S, Simmons A, Soininen H (2012): Education increases reserve against Alzheimer's disease-evidence from structural MRI analysis. Neuroradiology 54:929-938.
42. Lo RY, Jagust WJ (2013): Effect of cognitive reserve markers on Alzheimer pathologic progression. Alzheimer Dis Assoc Disord 27:343-350.
43. Lu PH, Thompson PM, Leow A, Lee GJ, Lee A, Yanovsky I, Parikshak N, Khoo T, Wu S, Geschwind D, Bartzokis G (2011): Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: A tensor-based morphometry study. J Alzheimers Dis 23:433-442.
44. Manly JJ, Schupf N, Tang MX, Stern Y (2005): Cognitive decline and literacy among ethnically diverse elders. J Geriatr Psychiatry Neurol 18:213-217.
45. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. (2011): The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:263-269.
46. Miller MI, Priebe CE, Qiu A, Fischl B, Kolasny A, Brown T, Park Y, Ratnanather JT, Busa E, Jovicich J, Yu P, Dickerson BC, Buckner RL (2009): Collaborative computational anatomy: An MRI morphometry study of the human brain via diffeomorphic metric mapping. Human Brain Mapp 30:2132-2141.
47. Miller MI, Younes L, Ratnanather JT, Brown T, Trinh H, Postell E, Lee DS, Wang MC, Mori S, O'Brien R, Albert M (2013): The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease. Neuroimage Clin 3:352-360.
48. Miller MI, Younes L, Trouve A (2014): Diffeomorphometry and geodesic positioning systems for human anatomy. Technology 2:36.
49. Miller MI, Younes L, Ratnanather JT, Brown T, Trinh H, Lee DS, Tward D, Mahon PB, Mori S, Albert M (2015): Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: The BIOCARD cohort. Neurobiol Aging 36 (Suppl 1):S3-S10.
50. Moghekar A, Li S, Lu Y, Li M, Wang MC, Albert M, O'Brien R (2013): CSF biomarker changes precede symptom onset of mild cognitive impairment. Neurology 81:1753-1758.
51. Morris JC (1993): The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 43:2412-2414.
52. Munn MA, Alexopoulos J, Nishino T, Babb CM, Flake LA, Singer T, Ratnanather JT, Huang H, Todd RD, Miller MI, Botteron KN (2007): Amygdala volume analysis in female twins with major depression. Biol Psychiatry 62:415-422.
53. Nelson HE (1982) The National Adult Reading Test (NART): Test manual. Windsor, UK: Nfer-Nelson.
54. Pettigrew C, Soldan A, Li S, Lu Y, Wang MC, Selnes OA, Moghekar A, O'Brien R, Albert M, The Biocard Research T (2013): Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer's disease. Cogn Neurosci 4:136-142.
55. Protas HD, Chen K, Langbaum JB, Fleisher AS, Alexander GE, Lee W, Bandy D, de Leon MJ, Mosconi L, Buckley S, Truran-Sacrey D, Schuff N, Weiner MW, Caselli RJ, Reiman EM (2013): Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol 70:320-325.
56. Querbes O, Aubry F, Pariente J, Lotterie JA, Demonet JF, Duret V, Puel M, Berry I, Fort JC, Celsis P (2009): Early diagnosis of Alzheimer's disease using cortical thickness: Impact of cognitive reserve. Brain 132:2036-2047.
57. Reed BR, Mungas D, Farias ST, Harvey D, Beckett L, Widaman K, Hinton L, DeCarli C (2010): Measuring cognitive reserve based on the decomposition of episodic memory variance. Brain 133:2196-2209.
58. Reuter-Lorenz PA, Cappell KA (2008): Neurocognitive aging and the compensation hypothesis. Curr Dir Psychol Sci 17:177-182.
59. Richards M, Sacker A (2003): Lifetime antecedents of cognitive reserve. J Clin Exp Neuropsychol 25:614-624.
60. Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC (2006): Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol 5:828-834.
61. Rusinek H, De Santi S, Frid D, Tsui WH, Tarshish CY, Convit A, de Leon MJ (2003): Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 229:691-696.
62. Sanfilipo MP, Benedict RH, Zivadinov R, Bakshi R (2004): Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: The proportion vs. residual method. Neuroimage 22:1732-1743.
63. Scarmeas N, Levy G, Tang MX, Manly J, Stern Y (2001): Influence of leisure activity on the incidence of Alzheimer's disease. Neurology 57:2236-2242.
64. Schofield PW, Mosesson RE, Stern Y, Mayeux R (1995): The age at onset of Alzheimer's disease and an intracranial area measurement. A relationship. Arch Neurol 52:95-98.
65. Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B (2004): A hybrid approach to the skull stripping problem in MRI. Neuroimage 22:1060-1075.
66. Siedlecki KL, Stern Y, Reuben A, Sacco RL, Elkind MS, Wright CB (2009): Construct validity of cognitive reserve in a multiethnic cohort: The Northern Manhattan Study. J Int Neuropsychol Soc 15:558-569.
67. Soldan A, Pettigrew C, Li S, Wang MC, Moghekar A, Selnes OA, Albert M, O'Brien R (2013): Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease. Neurobiol Aging 34:2827-2834.
68. Sole-Padulles C, Bartres-Faz D, Junque C, Vendrell P, Rami L, Clemente IC, Bosch B, Villar A, Bargallo N, Jurado MA, Barrios M, Molinuevo JL (2009): Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 30:1114-1124.
69. Speer ME, Soldan A (2015): Cognitive reserve modulates ERPs associated with verbal working memory in healthy younger and older adults. Neurobiol Aging 36:1424-1434.
70. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011): Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:280-292.
71. Springer MV, McIntosh AR, Winocur G, Grady CL (2005): The relation between brain activity during memory tasks and years of education in young and older adults. Neuropsychology 19:181-192.
72. Staff RT, Murray AD, Deary IJ, Whalley LJ (2004): What provides cerebral reserve? Brain 127:1191-1199.
73. Steffener J, Reuben A, Rakitin BC, Stern Y (2011): Supporting performance in the face of age-related neural changes: Testing mechanistic roles of cognitive reserve. Brain Imaging Behav 5:212-221.
74. Stern Y (2009): Cognitive reserve. Neuropsychologia 47:2015-2028.
75. Thal DR, Rub U, Orantes M, Braak H (2002): Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800.
76. Tupler LA, Krishnan KR, Greenberg DL, Marcovina SM, Payne ME, MacFall JR, Charles HC, Doraiswamy PM (2007): Predicting memory decline in normal elderly: Genetics, MRI, and cognitive reserve. Neurobiol Aging 28:1644-1656.
77. Valenzuela MJ, Sachdev P, Wen W, Chen X, Brodaty H (2008): Lifespan mental activity predicts diminished rate of hippocampal atrophy. PLoS One 3:e2598.
78. Wang MC, Brookmeyer R, Jewell NP (1993): Statistical models for prevalent cohort data. Biometrics 49:1-11.
79. Wechsler D (1981) Wechsler Adult Intelligence Scale-Revised Manual. New York: The Psychological Corporation.
80. Whitwell JL, Josephs KA, Murray ME, Kantarci K, Przybelski SA, Weigand SD, Vemuri P, Senjem ML, Parisi JE, Knopman DS, Boeve BF, Petersen RC, Dickson DW, Jack CR Jr (2008): MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study. Neurology 71:743-749.
81. Wirth M, Villeneuve S, La Joie R, Marks SM, Jagust WJ (2014): Gene-environment interactions: Lifetime cognitive activity, APOE genotype, and beta-amyloid burden. J Neurosci 34:8612-8617.
82. Wolf H, Julin P, Gertz HJ, Winblad B, Wahlund LO (2004): Intracranial volume in mild cognitive impairment, Alzheimer's disease and vascular dementia: Evidence for brain reserve? Int J Geriatr Psychiatry 19:995-1007.
83. Woods SP, Weber E, Cameron MV, Dawson MS, Delano-Wood L, Bondi MW, Grant I (2010): Spontaneous strategy use protects against visual working memory deficits in older adults infected with HIV. Arch Clin Neuropsychol 25:724-733.
84. Younes L, Albert M, Miller MI (2014): Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease. Neuroimage Clin 5:178-187.
85. Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, Chui HC (2005): Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol 57:896-903.